EXCLUSIVE: Longeveron Says 'The Phase 2a Trial Is Designed To Measure Brain Anatomy Using MRI, And Include Detailed Assessments Of The Inflammatory And Vascular Systems Thought To Contribute To The Worsening Of Alzhaimer's Disease'